Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

521 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Gill HS, et al. Am J Clin Nutr. 2001 Dec;74(6):833-9. doi: 10.1093/ajcn/74.6.833. Am J Clin Nutr. 2001. PMID: 11722966 Clinical Trial.
Probiotics to enhance anti-infective defences in the gastrointestinal tract.
Gill HS. Gill HS. Best Pract Res Clin Gastroenterol. 2003 Oct;17(5):755-73. doi: 10.1016/s1521-6918(03)00074-x. Best Pract Res Clin Gastroenterol. 2003. PMID: 14507586 Review.
Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice.
Cross ML, Mortensen RR, Kudsk J, Gill HS. Cross ML, et al. Among authors: gill hs. Med Microbiol Immunol. 2002 May;191(1):49-53. doi: 10.1007/s00430-002-0112-7. Med Microbiol Immunol. 2002. PMID: 12137199
Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.
Shu Q, Gill HS. Shu Q, et al. Among authors: gill hs. FEMS Immunol Med Microbiol. 2002 Sep 6;34(1):59-64. doi: 10.1111/j.1574-695X.2002.tb00603.x. FEMS Immunol Med Microbiol. 2002. PMID: 12208607
Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M, Prasad J, Gill H, Stevenson L, Gopal P. Ahmed M, et al. J Nutr Health Aging. 2007 Jan-Feb;11(1):26-31. J Nutr Health Aging. 2007. PMID: 17315077 Clinical Trial.
Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies?
Cross ML, Gill HS. Cross ML, et al. Among authors: gill hs. Int Arch Allergy Immunol. 2001 Jun;125(2):112-9. doi: 10.1159/000053804. Int Arch Allergy Immunol. 2001. PMID: 11435727 Review.
Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro.
Zhou JS, Rutherfurd KJ, Gill HS. Zhou JS, et al. Among authors: gill hs. J Food Prot. 2005 Nov;68(11):2459-64. doi: 10.4315/0362-028x-68.11.2459. J Food Prot. 2005. PMID: 16300090
Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001.
Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Sheih YH, et al. Among authors: gill hs. J Am Coll Nutr. 2001 Apr;20(2 Suppl):149-56. doi: 10.1080/07315724.2001.10719027. J Am Coll Nutr. 2001. PMID: 11349938 Clinical Trial.
Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
Zhou JS, Gopal PK, Gill HS. Zhou JS, et al. Among authors: gill hs. Int J Food Microbiol. 2001 Jan 22;63(1-2):81-90. doi: 10.1016/s0168-1605(00)00398-6. Int J Food Microbiol. 2001. PMID: 11205957
Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses.
Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Chiang BL, et al. Among authors: gill hs. Eur J Clin Nutr. 2000 Nov;54(11):849-55. doi: 10.1038/sj.ejcn.1601093. Eur J Clin Nutr. 2000. PMID: 11114680 Clinical Trial.
521 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback